bpc 157 case report human adverse event BPC-157 Data: Promising, But Not Proven In Humans, Early animal studies suggest BPC-157 may reduce pain behaviors in inflammatory and non-inflammatory models, including reduced allodynia. But this The Hidden Risks of BPC‑157:
Description
Jun 2021;13(6):e15998

Several of its forms exist

ACS Food Sci Technol
doi: 10.1016/j.biopha.2018.07.115
For gastrointestinal indications, oral BPC-157 is appropriate because the gut is the target and the peptide does not need to travel further

The dose differs when you compare oral supplements with injections
